EUVIMEDEUVIMED entdecken
Open Access

Neuromedin B excites central lateral amygdala neurons and reduces cardiovascular output and fear‐potentiated startle

Cody A Boyle iD, Saobo Lei iD

Journal of Cellular Physiology · 2023

DOI: 10.1002/jcp.31020 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular Physiology, 2023. Verfasst von Cody A Boyle und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, School of Medicine and Health Sciences, University of North Dakota, Grand Forks, North Dakota, USA. Hauptthemen laut MEDLINE: Peptides, Neurokinin B. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 145 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIMH NIH HHS, National Institute of Mental Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neuromedin B (NMB) and gastrin‐releasing peptide (GRP) are the two mammalian analogs in the bombesin peptide family that exert a variety of actions including emotional processing, appetitive behaviors, cognition, and tumor growth. The bombesin‐like peptides interact with three receptors: the NMB‐preferring bombesin 1 (BB1) receptors, the GRP‐preferring bombesin 2 (BB2) receptors and the orphan bombesin 3 (BB3) receptors. Whereas, injection of bombesin into the central amygdala reduces satiety and modulates blood pressure, the underlying cellular and molecular mechanisms have not been determined. As administration of bombesin induces the expression of Fos in the lateral nucleus of the central amygdala (CeL) which expresses BB1 receptors, we probed the effects of NMB on CeL neurons using in vitro and in vivo approaches. We showed that activation of the BB1 receptors increased action potential firing frequency recorded from CeL neurons via inhibition of the inwardly rectifying K + (Kir) channels. Activities of phospholipase Cβ and protein kinase C were required, whereas intracellular Ca 2+ release was unnecessary for BB1 receptor‐elicited potentiation of neuronal excitability. Application of NMB directly into the CeA reduced blood pressure and heart rate and significantly reduced fear‐potentiated startle. We may provide a cellular and molecular mechanism whereby bombesin‐like peptides modulate anxiety and fear responses in the amygdala.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PeptidesNeurokinin BAnimalsAmygdalaBombesinFearMammalsNeuronsReceptors, Bombesin

Stichwörter der Autor:innen

G proteinK+ channelsamygdalaexcitabilityfearneuromedin B

Substanzen

Bombesinneuromedin BPeptidesReceptors, BombesinNeurokinin B

Autor:innen und Institutionen

  • Department of Biomedical Sciences, School of Medicine and Health Sciences, University of North Dakota, Grand Forks, North Dakota, USA.

ORCID-Profile: Cody A Boyle, Saobo Lei

Förderung

  • NIMH NIH HHS
  • National Institute of Mental Health

Zitieren

APA

Boyle, C. A., & Lei, S. (2023). Neuromedin B excites central lateral amygdala neurons and reduces cardiovascular output and fear‐potentiated startle. Journal of Cellular Physiology. https://doi.org/10.1002/jcp.31020

Vancouver

Boyle CA, Lei S. Neuromedin B excites central lateral amygdala neurons and reduces cardiovascular output and fear‐potentiated startle. Journal of Cellular Physiology. 2023. doi:10.1002/jcp.31020

BibTeX
@article{Boyle2023,
  author = {Boyle, Cody A and Lei, Saobo},
  title = {Neuromedin B excites central lateral amygdala neurons and reduces cardiovascular output and fear‐potentiated startle},
  journal = {Journal of Cellular Physiology},
  year = {2023},
  doi = {10.1002/jcp.31020}
}
Kostenlos starten →